|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0020438,
umls-concept:C0030685,
umls-concept:C0034656,
umls-concept:C0071778,
umls-concept:C0391871,
umls-concept:C0439834,
umls-concept:C0680255,
umls-concept:C1283071,
umls-concept:C1372798,
umls-concept:C1963578
|
|
pubmed:issue |
3 Pt 1
|
|
pubmed:dateCreated |
1998-9-24
|
|
pubmed:abstractText |
We examined the physiological effects and tolerance of UroPhos-K, a slow release neutral form of potassium phosphate (155 mg. phosphate and 8 mEq. potassium per tablet) in patients with absorptive hypercalciuria.
|
|
pubmed:grant |
|
|
pubmed:keyword |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0022-5347
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
160
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
664-8
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:9720517-Adult,
pubmed-meshheading:9720517-Aged,
pubmed-meshheading:9720517-Calcium,
pubmed-meshheading:9720517-Delayed-Action Preparations,
pubmed-meshheading:9720517-Double-Blind Method,
pubmed-meshheading:9720517-Female,
pubmed-meshheading:9720517-Humans,
pubmed-meshheading:9720517-Male,
pubmed-meshheading:9720517-Metabolic Diseases,
pubmed-meshheading:9720517-Middle Aged,
pubmed-meshheading:9720517-Phosphates,
pubmed-meshheading:9720517-Potassium Compounds
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Physiological effects of slow release potassium phosphate for absorptive hypercalciuria: a randomized double-blind trial.
|
|
pubmed:affiliation |
Center for Mineral Metabolism and Clinical Research, University of Texas Southwestern Medical Center, Dallas, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial
|
